CAS 852403-68-0

Metaflumizone

CAS : 852403-68-0

Formule : C₂₄H₁₆F₆N₄O₂

Couleur et forme : White To Off-White Solid

Masse moléculaire : 506.41

Ref: 4Z-M-001001

Metaflumizone-d4

CAS : 852403-68-0

Formule : C₂₄H₁₂D₄F₆N₄O₂

Couleur et forme : White To Off-White Solid

Masse moléculaire : 510.43

Ref: 4Z-M-001003

(E)-Metaflumizone

Produit contrôlé

CAS : 852403-68-0

Formule : C₂₄H₁₆F₆N₄O₂

Couleur et forme : Neat

Masse moléculaire : 506.40

Ref: 04-C14918520

(E)-Metaflumizone 100 µg/mL in Acetonitrile

Produit contrôlé

CAS : 852403-68-0

Formule : C₂₄H₁₆F₆N₄O₂

Couleur et forme : Single Solution

Masse moléculaire : 506.40

Ref: 04-A14918520AL-100

(E)-Metaflumizone

Produit contrôlé

CAS : 852403-68-0

Applications (E)-Metaflumizone is used as UV absorber for reducing E/Z isomerization of pesticides.It is the (E) Isomer of Metaflumizone (M225825), which is a semicarbazone insecticide that works by blocking sodium channel in target insects resulting in paralyzation associated with blocking nerve activity. Metaflumizone is useful as a heartworm control treatment.
References Ishaque, M., et al.: U.S. Pat. Appl. Publ. 10 pp. (2011);Zhang, Zhe,, et al.: J. Integrat. Agri. 11, 1145 (2012); Kuhn, D., et al.: Modern. Crop. Protect. Compound., 3, 1273 (2012);

Formule : C₂₄H₁₆F₆N₄O₂

Couleur et forme : Colourless To White

Masse moléculaire : 506.40

Ref: TR-M225826

(E)-Metaflumizone

CAS : 852403-68-0

(E)-Metaflumizone is an anticancer drug that induces apoptosis in human tumor cells. It is a potent inhibitor of protein kinases, including Chinese hamster ovary cell kinase and geniposide analogs. (E)-Metaflumizone has been shown to inhibit the growth of cancer cells by blocking the activity of key enzymes involved in cell division and proliferation. This drug also inhibits the activity of protein kinases, which play a crucial role in cancer development and progression. In addition, (E)-Metaflumizone has been found to be effective against a wide range of cancer types, making it a promising candidate for further clinical development.

Formule : C₂₄H₁₆F₆N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 506.4 g/mol

Ref: 3D-CJB40368